Hepatic PKA Mediates Liver and Pancreatic α-Cell Cross Talk

Area of Science:

• Endocrinology
• Metabolic Signaling
• Molecular Biology

Background:

• Glucagon is a key hormone regulating hepatic glucose production and amino acid metabolism.
• Inhibition of the liver glucagon receptor (GCGR) leads to elevated plasma amino acids and pancreatic alpha-cell proliferation, forming a liver-alpha-cell loop.
• The specific downstream signaling molecules mediating this loop remain incompletely understood.

Purpose of the Study:

• To identify hepatic signaling molecules downstream of the GCGR that regulate the liver-alpha-cell loop.
• To elucidate the role of G-protein subunit alpha-s (GNAS) and its effectors, protein kinase A (PKA) and EPAC2 (exchange protein directly activated by cAMP 2), in this pathway.

Main Methods:

• Gene knockdown of liver GCGR, GNAS, PKA, and EPAC2 in mice.
• Assessment of hepatic amino acid catabolism gene expression.
• Measurement of plasma amino acid levels.
• Evaluation of pancreatic alpha-cell mass and proliferation.

Main Results:

• Knockdown of GCGR, GNAS, and PKA, but not EPAC2, suppressed hepatic amino acid catabolism, leading to hyperaminoacidemia and alpha-cell hyperplasia.
• Activating liver PKA was sufficient to reverse the hyperaminoacidemia and alpha-cell hyperplasia observed upon GCGR blockade.
• These findings implicate the GCGR-GNAS-PKA pathway in controlling amino acid metabolism and the liver-alpha-cell loop.

Conclusions:

• Hepatic GCGR signaling primarily acts through PKA to regulate amino acid catabolism.
• PKA is a critical mediator in the liver-alpha-cell loop, influencing both amino acid levels and alpha-cell mass.
• Targeting hepatic PKA may offer therapeutic potential for metabolic disorders involving glucagon signaling.